Focus on Human Friendly Medical Technology


M+TA is a leading biomedical technology provider of cutting-edge technologies and products. We started our R&D development activities in 2005 where we worked on advanced material science on special ionic quantum properties on medical material application.  After focusing on improving material quality by boasting electron mobility within Super Materials that exhibit excellent antibacterial and filtration properties, we established M+TA Technology in 2019. Our name is an acronym for Medical+ Technology Application. We aim to develop various medical and general application products using M+ Antibacterial, Micron+ Fiber and Super Micron+ Fiber Technology.

Through advance application of M+ Antibacterial and Super Micron+ Fiber Technology, we hope to cater for a wide variety of applications such as biomedical, tissue engineering, pharmaceutical, energy, filtration, material sciences, textile, agriculture, cosmetics, and many others.

Medical Plus Technology Application doesn't have any updates to show yet.

Please login or sign up to see the discussions.



Equity Crowdfunding is risky. You are investing in early stage companies which may not do well and could even fail. You could lose part or all of your investment. You may not be able to sell your shares easily.

Investments are speculative and carry high risks. To decrease exposure, these types of investments should only be made as part of a diversified portfolio. Spread your risks and only invest money that you can afford to lose. pitchIN wants all investors to understand these risks and make careful investment decisions. You are also encouraged to seek independent advice.